The Cooper Companies, Inc. (COO)

Market Cap	12.08B -25.9%
Revenue (ttm)	4.15B +5.7%
Net Income	401.40M -3.4%
EPS	2.01 -3.0%
Shares Out	195.11M
PE Ratio	30.61
Forward PE	13.12
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,606,242
Open	61.26
Previous Close	61.45
Day's Range	60.43 - 62.20
52-Week Range	58.89 - 89.83
Beta	0.89
Analysts	Buy
Price Target	91.07 (+47.08%)
Earnings Date	Jun 4, 2026

About COO

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women’s health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cor...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1980
• Employees: 15,000
• Stock Exchange: NASDAQ
• Ticker Symbol: COO
• Website: https://www.coopercos.com

Financial Performance

In fiscal year 2025, The Cooper Companies's revenue was $4.09 billion, an increase of 5.06% compared to the previous year's $3.90 billion. Earnings were $374.90 million, a decrease of -4.44%.

Analyst Summary

According to 17 analysts, the average rating for COO stock is "Buy." The 12-month stock price target is $91.07, which is an increase of 47.08% from the latest price.

Price Target

$91.07

(47.08% upside)

Analyst Consensus: Buy